Patient dies in Kite drug trial – Chemical & Engineering News
|
Patient dies in Kite drug trial
Chemical & Engineering News In clinical trials, CAR-T therapies can almost magically melt tumors away. But putting live, supercharged cells into the body is a new frontier. In the case of the Kite drug, a lymphoma treatment called KTE-C19, the patient’s new T cells released an … |
Hamilton Spectator |
Ontario sets aside $32 million to combat dangerously long waits for stem cell transplants
Hamilton Spectator Laura Hillier’s legacy lives on as the province has pledged $32 million in new funding this year to shorten dangerously-long wait lists for stem cell transplants. The money set aside in the 2017 budget means 150 more Ontarians a year will receive the … |
生物通 |
如何利用CRISPR/Cpf1系统实现多重基因编辑
生物通 生物通报道 CRISPR基因组编辑领域可谓日新月异，每月都有新成果涌现。不久前，CRISPR技术先驱张锋（Feng Zhang）领导的团队发表文章，介绍了如何使用Cpf1来进行多重的基因组编辑。与常用的Cas9相比，Cpf1将多重编辑大大 … |
生物通 |
如何利用CRISPR/Cpf1系统实现多重基因编辑
生物通 生物通报道 CRISPR基因组编辑领域可谓日新月异，每月都有新成果涌现。不久前，CRISPR技术先驱张锋（Feng Zhang）领导的团队发表文章，介绍了如何使用Cpf1来进行多重的基因组编辑。与常用的Cas9相比，Cpf1将多重编辑大大 … |
Wired.co.uk |
CRISPR kills HIV and eats Zika ‘like Pac-man’. Its next target? Cancer
Wired.co.uk Last week, a group of biologists published research detailing how they hid an anti-HIV CRISPR system inside another type of virus capable of sneaking past a host’s immune system. What’s more, the virus replicated and snipped HIV from infected cells … |
Oncology Nurse Advisor |
CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy
Oncology Nurse Advisor DENVER,CO — The oncology nurses’ role in monitoring and early recognition of the signs and symptoms of chimeric antigen receptor T cell (CAR T-cell) toxicities is significant considering the potential severity of these adverse effects, according to a … |